Skip to content

What is the Optimal Technique for Hydrodistention?

What is the Optimal Technique for Hydrodistention? First Prospective Study Evaluating the Effect of Pressure, Duration and Number of Hydrodistentions on Patients with Interstitial Cystitis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05456308
Enrollment
96
Registered
2022-07-13
Start date
2022-07-01
Completion date
2024-03-31
Last updated
2024-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Pain Syndrome, Interstitial Cystitis

Keywords

Hydrodistension

Brief summary

This research study is being done to learn what is the best way to perform hydrodistention. Eligible participants will be enrolled and have follow-up for three months after surgery. The study team hypothesizes that changes in hydrodistention technique, including pressure, number of distention, and duration of distention, leads to no or minimal changes in symptom improvement for patients with Interstitial cystitis/bladder pain syndrome (IC/BPS).

Detailed description

Hydrodistention is a procedure designed to treat bladder and pelvic symptoms in patients with interstitial cystitis. A camera is placed inside the bladder and the bladder is filled with fluid. This procedure resets the signals between the bladder and brain, in order to reduce the symptoms of interstitial cystitis (such as bladder pain, urinary urgency/frequency/dysuria, incontinence, incomplete emptying, etc). However, it is still unknown the best way to perform hydrodistention. Doctors do not know how much fluid to put in the bladder, how long to keep the fluid in the bladder, and how many times to fill the bladder.

Interventions

PROCEDUREHydrodistention during cystoscope

Hydrodistention for treatment of interstitial cystitis will be performed. Participants will be randomly selected to one of the arms described. There are three variables that they will be assigned: the pressure of fluid in the bladder that will be filled, the duration of time that the fluid will be held in the bladder, and the number of times the procedure is completed.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Patients and statistician blinded

Intervention model description

Participants will be randomly selected to one of the arms described. There are three variables that they will be assigned: the pressure of fluid in the bladder that will be filled, the duration of time that the fluid will be held in the bladder, and the number of times the procedure is completed.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with IC/BPS who have failed first/second line treatments (behavioral therapy, medications) for greater than 3 months * Have not had hydrodistention performed in the past 3 months * Have not had botox or Percutaneous tibial nerve stimulation (PTNS) performed in the past 3 months

Exclusion criteria

* Patients with known hunner's lesions * Patients with interstim * Patients with positive urinalysis/culture consistent with urinary tract infection (UTI) * History of urethral, bladder, prostate, uterine, cervical, vaginal cancer * History of augmentation cystoplasty or cystectomy * History of urethral diverticulum, urethral stricture, pelvic radiation * Patients with spinal cord injuries * History of dementia, parkinson's disease, multiple sclerosis, spina bifida, paraplegia/quadriplegia, cerebral palsy, stroke * Neurogenic bladder patients * Anuric patients * Tuberculous cystitis * Cyclophosphamide treatment * Pregnant patients

Design outcomes

Primary

MeasureTime frameDescription
Changes in the interstitial cystitis symptom index (ICSI) from baseline to 1-monthbaseline to 1 monthIdentify the optimal technique for hydrodistention, including the optimal pressure (30 vs 80cc), number of hydrodistentions (one vs two), duration of each hydrodistention (one vs two minutes) as quantified by Changes in the interstitial cystitis symptom index (ICSI)f rom baseline to 1-month. The O'Leary-Sant questionnaire is composed of the Interstitial Cystitis Symptom Index (ICSI) and Problem Index (ICPI) which contains four questions related to urinary and pain symptoms. For the ICSI (score range: 0-19 points), 3 of the 4 questions utilize a range of 0-5 with 0 indicating the symptom is never experienced and 5 indicating the symptom is almost always experienced. The fourth question utilizes a range of 0-4 with 0 indicating the symptom is never experienced and 4 indicating the symptom is usually experienced. For the ICPI (score range: 0-16 points), all four questions utilize a range of 0-4 with 0 indicating it is no problem and 4 indicating it is a big problem.

Secondary

MeasureTime frameDescription
Changes in the genitourinary pain index (GUPI) from baseline to 1- monthbaseline to 1- monthThe GUPI questionnaire (score range: 0 - 45) contains nine overarching items related to urinary symptoms, pain, and impact on quality of life. A higher score denoting worse symptoms.
Changes in the genitourinary pain index (GUPI) from baseline to 1-weekbaseline to 1-weekThe GUPI questionnaire (score range: 0 - 45) contains nine overarching items related to urinary symptoms, pain, and impact on quality of life. A higher score denoting worse symptoms.
Changes in the genitourinary pain index (GUPI) baseline to 3-monthsbaseline to 3-monthsThe GUPI questionnaire (score range: 0 - 45) contains nine overarching items related to urinary symptoms, pain, and impact on quality of life. A higher score denoting worse symptoms.
Complication rates between different hydrodistention parameters (pressure, number of distention, and duration of distention)up to 30 days (after hydrodistention)These include bladder rupture, urinary tract infection/sepsis, prolonged retention, unplanned readmissions within 30 days.
Changes in the interstitial cystitis symptom index (ICSI) from baseline to 3-monthsbaseline to 3-monthsThe O'Leary-Sant questionnaire is composed of the Interstitial Cystitis Symptom Index (ICSI) and Problem Index (ICPI) which contains four questions related to urinary and pain symptoms. For the ICSI (score range: 0-19 points), 3 of the 4 questions utilize a range of 0-5 with 0 indicating the symptom is never experienced and 5 indicating the symptom is almost always experienced. The fourth question utilizes a range of 0-4 with 0 indicating the symptom is never experienced and 4 indicating the symptom is usually experienced. For the ICPI (score range: 0-16 points), all four questions utilize a range of 0-4 with 0 indicating it is no problem and 4 indicating it is a big problem.
Time spent in the post-anesthesia care unit (minutes)After procedure (approximate time frame is 60 minutes)
Number of morphine milligram equivalents (MME) given in the post-anesthesia care unitAfter procedure (approximate time frame is 1 hour)
Changes in the interstitial cystitis symptom index (ICSI) from baseline to 1-weekbaseline to 1-weekThe O'Leary-Sant questionnaire is composed of the Interstitial Cystitis Symptom Index (ICSI) and Problem Index (ICPI) which contains four questions related to urinary and pain symptoms. For the ICSI (score range: 0-19 points), 3 of the 4 questions utilize a range of 0-5 with 0 indicating the symptom is never experienced and 5 indicating the symptom is almost always experienced. The fourth question utilizes a range of 0-4 with 0 indicating the symptom is never experienced and 4 indicating the symptom is usually experienced. For the ICPI (score range: 0-16 points), all four questions utilize a range of 0-4 with 0 indicating it is no problem and 4 indicating it is a big problem.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026